| Charles L Calhoun, MD | |
|
2616 Warm Springs Rd, Columbus, GA 31904-5642 | |
| (706) 321-3491 | |
| (706) 660-9191 |
| Full Name | Charles L Calhoun |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 2616 Warm Springs Rd, Columbus, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518920529 | NPI | - | NPPES |
| 00093178A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 17594 (Georgia) | Primary |
| Entity Name | Valley Healthcare System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952599623 PECOS PAC ID: 8628988276 Enrollment ID: O20040528000880 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into a securities purchase agreement to sell, subject to certain closing conditions, up to $25.0 million of shares of its Series 8 Non-Convertible Preferred Stock, warrants to purchase up to 22,563,177 shares of common stock and an additional investment right to purchase up to $25.0 million of shares of its Series 9 Convertible Preferred Stock, in a registered offering to a single life sciences institutional investor.
A drug targeting one specific receptor may provide the first effective approach to treatment for the common problem of memory loss after surgery and anesthesia, according to an experimental study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
Running multiple marathons does not increase the risk of atherosclerosis, according to research published today in the European Journal of Preventive Cardiology.
Monitored by scientists at Kessler Foundation, six people with traumatic spinal cord injuries tested Ekso, the robotic exoskeleton from Ekso Bionics that enables wheelchair users to stand and walk.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles L Calhoun, MD 2616 Warm Springs Rd, Columbus, GA 31904-5642 Ph: (706) 321-3491 | Charles L Calhoun, MD 2616 Warm Springs Rd, Columbus, GA 31904-5642 Ph: (706) 321-3491 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into a securities purchase agreement to sell, subject to certain closing conditions, up to $25.0 million of shares of its Series 8 Non-Convertible Preferred Stock, warrants to purchase up to 22,563,177 shares of common stock and an additional investment right to purchase up to $25.0 million of shares of its Series 9 Convertible Preferred Stock, in a registered offering to a single life sciences institutional investor.
A drug targeting one specific receptor may provide the first effective approach to treatment for the common problem of memory loss after surgery and anesthesia, according to an experimental study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
Running multiple marathons does not increase the risk of atherosclerosis, according to research published today in the European Journal of Preventive Cardiology.
Monitored by scientists at Kessler Foundation, six people with traumatic spinal cord injuries tested Ekso, the robotic exoskeleton from Ekso Bionics that enables wheelchair users to stand and walk.
› Verified 3 days ago
James G Brooks Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Dr. Steven Lloyd Henslee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2012 10th Ave, Columbus, GA 31901 Phone: 706-324-4321 Fax: 706-324-4385 | |
Dr. William Jay White, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1030 13th St, Columbus, GA 31901 Phone: 706-327-8181 Fax: 706-596-6658 | |
Bret Crumpton, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Sterling L Cannon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Nicholas Duquette Mayfield, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2616 Warm Springs Rd, Columbus, GA 31904 Phone: 706-323-3491 Fax: 706-660-9191 | |
Dr. Joseph Frank Ceravolo, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1240 Brookstone Centre Parkway, Columbus, GA 31904 Phone: 706-323-8127 Fax: 706-596-4837 |